Evonik to expand production capacities in China
Market for triacetonamine derivatives is booming
Main applications in the automotive and construction industries
Production scheduled to begin at the end of 2011
Demand for triacetonamine derivatives (TAA derivatives) has kept rising for several years. Evonik Industries is taking advantage of the economic opportunities afforded by this situation and is considerably expanding its production capacities for these special derivatives in China. The foundations for a new plant will be laid as early as this year.
Currently, Evonik produces the derivatives in a joint venture Evonik Tianda (Liaoyang) Chemical Additive Co., Ltd. at the Liaoyang site in northeaster China. The existing production capacities are to be moved within the Liaoyang region to the Aromatic Site (LAS), one of the country's largest petrochemical sites, and will also be significantly increased. Full production is scheduled to commence in the fourth quarter of 2011.
Apart from the plant in Liaoyang, Evonik has further production capacities at Marl Chemical Park in Germany.
The company is already one of the world's leading suppliers of TAA derivatives. These are essential intermediates for the production of hindered amine light stabilizers H.A.L.S. The stabilizers improve the properties of plastics that are subject to intensive light radiation. The main applications are in the automotive and construction industries as well as agricultural films.
Evonik Industries is the creative industrial group from Germany. In our core business of specialty chemicals, we are a global leader. In addition, Evonik is an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our company’s performance is shaped by creativity, specialization, continuous self-renewal, and reliability.
Evonik is active in over 100 countries around the world. In its fiscal year 2009 about 39,000 employees generated sales of about €13.1 billion and an operating profit (EBITDA) of about €2.0 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.